Back to Search
Start Over
Construction of warfarin population pharmacokinetics and pharmacodynamics model in Han population based on Bayesian method.
- Source :
-
Scientific reports [Sci Rep] 2024 Jun 27; Vol. 14 (1), pp. 14846. Date of Electronic Publication: 2024 Jun 27. - Publication Year :
- 2024
-
Abstract
- The purpose of this paper is to study the genetic polymorphisms of related gene loci (CYP2C9*3, VKORC1-1639G > A) based on demographic and clinical factors, and use the maximum a posterior Bayesian method to construct a warfarin individualized dose prediction model in line with the Chinese Han population. Finally, the built model is compared and analyzed with the widely used models at home and abroad. In this study, a total of 5467 INR measurements are collected from 646 eligible subjects in our hospital, and the maximum a posterior Bayesian method is used to construct a warfarin dose prediction that conforms to the Chinese Han population on the basis of the Hamberg model. The model is verified and compared with foreign models. This study finds that body weight and concomitant use of amiodarone have a significant effect on the anticoagulant effect of warfarin. The model can provide an effective basis for individualized and rational dosing of warfarin in Han population more accurately. In the performance of comparison with different warfarin dose prediction models, the new model has the highest prediction accuracy, and the prediction percentage is as high as 72.56%. The dose predicted by the Huang model is the closest to the actual dose of warfarin. The population pharmacokinetics and pharmacodynamics model established in this study can better reflect the distribution characteristics of INR values after warfarin administration in the Han population, and performs better than the models reported in the literature.<br /> (© 2024. The Author(s).)
- Subjects :
- Adult
Aged
Female
Humans
Male
Middle Aged
Bayes Theorem
China
International Normalized Ratio
East Asian People
Anticoagulants administration & dosage
Anticoagulants pharmacokinetics
Cytochrome P-450 CYP2C9 genetics
Cytochrome P-450 CYP2C9 metabolism
Vitamin K Epoxide Reductases genetics
Warfarin administration & dosage
Warfarin pharmacokinetics
Subjects
Details
- Language :
- English
- ISSN :
- 2045-2322
- Volume :
- 14
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Scientific reports
- Publication Type :
- Academic Journal
- Accession number :
- 38937509
- Full Text :
- https://doi.org/10.1038/s41598-024-65048-7